Susan Hasty, Publisher
Table of Contents . . . April 29th, 1996Non-Subscriber - Summaries Only
Cancer Gene Therapy - Aerosolized Administration of Lipid-p53 Gene Complexes Stops Lung Cancer
Cancer Gene Therapy - Innovative Drug Strategies Show Promise
Cancer Gene Therapy - Trials Begin for Anticancer Agent Onyx-015
Cancer Gene Therapy - Wild-Type p53 Expression Reduces Tumorigenicity in a Variety of Cancers
Cancer Vaccines - Metastatic Melanoma Vaccine Entered in National Clinical Trials
Animal Models (Gene Therapy) - Model Proves that Transduced Hematopoietic Stem Cells Differentiate In Vivo
Breast Cancer (Psychosocial) - Women Facing Cancer Surgery Fare Better with Psychological Support
Breast Cancer (Screening) - More Cancers Found When Mammography Is More Accessible
Breast Cancer (Screening) - SPECT Imaging Can Detect Cancer Early
Breast Cancer (Screening) - Technology Helps Detect Early Form of Cancer
Breast Disease (Markers) - Specific Estrogen Enzyme May Signal Neoplastic Disease
Chemotherapy - Agent Helps Reduce Kidney Toxicity Associated with Cisplatin
Monoclonal Antibodies - mAb Therapies Value Proven in Trials To Treat Cancers
Optical Spectroscopy - Light Used To Determine When Normal Cells Become Cancerous
Ovarian Cancer (Genetics) - Epidemiology of Cancer Related to BRCA1 Gene
Prostate Cancer (Diagnostics) - Abstinence from Sex Before PSA Testing Ensures Accurate Results
Transplantation (BMT) - Specific Antitumor Immunity Induced by Bone Marrow from Immunized Donors
Vaccine Development - Poliovirus Pathogenicity Abolished by Rhinovirus Gene Insert
Cancer Vaccines (Melanoma) - "Pre-Immunization of Mice with Irradiated B16-F10 Melanoma Cells Transfected to Secrete GM-CSF Coupled with GM-CSF Therapy Gave Superior Protection to Tumor Challenge Compared to Similar Treatment with Irra
Immunotherapy (Cancer) - "Therapy of Murine Tumors with p53 Wild Type Sequence Peptide-Based Vaccine."
Pathogenesis (HIV) - "The HIV-tat Protein is a Heparin-Binding Angiogenic Growth Factor."
Hammerhead Ribozymes - "Designing of Chimeric DNA/RNA Hammerhead Ribozymes to be Targeted Against AML1/MTG8 mRNA."